Chunk #22 — DISCUSSION

Source: Real-world observations on neuroinflammation-related drug responses in Alzheimer's disease.
Embedded: yes

Text

We identified drugs that might have a potential beneficial effect (levothyroxine, mirabegron and ropinirole) and a potential adverse effect (levetiracetam and quetiapine) in AD in patients with neuroinflammation-related conditions.